| Citation: | Su YH,Xia WZ,Huang X,et al.Research advances in the treatment of keloid with glucocorticoids[J].Chin J Burns Wounds,2023,39(9):886-890.DOI: 10.3760/cma.j.cn501225-20230602-00198.
|
| [1] |
中国整形美容协会瘢痕医学分会常务委员会专家组.中国瘢痕疙瘩临床治疗推荐指南[J].中国美容整形外科杂志,2018,29(5):前插3-前插14.DOI: 10.3969/j.issn.1673-7040.2018.05.001.
|
| [2] |
OgawaR.The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago[J].Plast Reconstr Surg,2022,149(1):79e-94e.DOI: 10.1097/PRS.0000000000008667.
|
| [3] |
LeeHJ,JangYJ.Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids[J].Int J Mol Sci,2018,19(3):711.DOI: 10.3390/ijms19030711.
|
| [4] |
SchmidtS,RainerJ,PlonerC,et al.Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance[J].Cell Death Differ,2004,11 Suppl 1:S45-55.DOI: 10.1038/sj.cdd.4401456.
|
| [5] |
ShengM,ChenY,LiH,et al.The application of corticosteroids for pathological scar prevention and treatment: current review and update[J/OL].Burns Trauma,2023,11:tkad009[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/36950503/.DOI: 10.1093/burnst/tkad009.
|
| [6] |
ShimbaA,IkutaK.Control of immunity by glucocorticoids in health and disease[J].Semin Immunopathol,2020,42(6):669-680.DOI: 10.1007/s00281-020-00827-8.
|
| [7] |
WuWS,WangFS,YangKD,et al.Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation[J].J Invest Dermatol,2006,126(6):1264-1271.DOI: 10.1038/sj.jid.5700274.
|
| [8] |
WangQ,ZhongY,LiZ,et al.Multitranscriptome analyses of keloid fibroblasts reveal the role of the HIF-1α/HOXC6/ERK axis in keloid development[J/OL].Burns Trauma,2022,10:tkac013[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/35547861/.DOI: 10.1093/burnst/tkac013.
|
| [9] |
SyedF,SinghS,BayatA.Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids[J].Wound Repair Regen,2013,21(1):88-102.DOI: 10.1111/j.1524-475X.2012.00862.x.
|
| [10] |
RutkowskiD,SyedF,MatthewsLC,et al.An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease[J].Br J Dermatol,2015,173(3):690-700.DOI: 10.1111/bjd.13752.
|
| [11] |
Ramos-RamírezP,TlibaO.Glucocorticoid receptor β (GRβ): beyond its dominant-negative function[J].Int J Mol Sci,2021,22(7):3649.DOI: 10.3390/ijms22073649.
|
| [12] |
YangY,LiuL,WuX,et al.CO2 fractional laser-assisted transdermal delivery of silk nanofiber carriers in a rabbit ear hypertrophic scar model[J/OL].Burns Trauma,2022,10:tkac040[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/36380852/.DOI: 10.1093/burnst/tkac040.
|
| [13] |
PhataleV,VaipheiKK,JhaS,et al.Overcoming skin barriers through advanced transdermal drug delivery approaches[J].J Control Release,2022,351:361-380.DOI: 10.1016/j.jconrel.2022.09.025.
|
| [14] |
SmithJC,BooneBE,OpalenikSR,et al.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways[J].J Invest Dermatol,2008,128(5):1298-1310.DOI: 10.1038/sj.jid.5701149.
|
| [15] |
YinQ,LouterJ,NiessenFB,et al.Intralesional corticosteroid administration in the treatment of keloids: a scoping review on injection methods[J].Dermatology,2023,239(3):462-477.DOI: 10.1159/000529220.
|
| [16] |
AndrewsJP,MarttalaJ,MacarakE,et al.Keloids: the paradigm of skin fibrosis-pathomechanisms and treatment[J].Matrix Biol,2016,51:37-46.DOI: 10.1016/j.matbio.2016.01.013.
|
| [17] |
XuH,ZhuZ,HuJ,et al.Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids[J].Cell Mol Immunol,2022,19(4):527-539.DOI: 10.1038/s41423-021-00834-1.
|
| [18] |
SartawiZ,BlackshieldsC,FaisalW.Dissolving microneedles: applications and growing therapeutic potential[J].J Control Release,2022,348:186-205.DOI: 10.1016/j.jconrel.2022.05.045.
|
| [19] |
KohE,FreedmanBR,RamazaniF,et al.Controlled delivery of corticosteroids using tunable tough adhesives[J].Adv Healthc Mater,2023,12(3):e2201000.DOI: 10.1002/adhm.202201000.
|
| [20] |
TanC,TanWD,SrivastavaR,et al.Dissolving triamcinolone-embedded microneedles for the treatment of keloids: a single-blinded intra-individual controlled clinical trial[J].Dermatol Ther (Heidelb),2019,9(3):601-611.DOI: 10.1007/s13555-019-00316-3.
|
| [21] |
YangY,XiaL,NingX,et al.Enhanced drug permeation into human keloid tissues by sonophoresis-assisted microneedling[J].SLAS Technol,2021,26(6):660-666.DOI: 10.1177/24726303211024568.
|
| [22] |
TheocharidisG,ThomasBE,SarkarD,et al.Single cell transcriptomic landscape of diabetic foot ulcers[J].Nat Commun,2022,13(1):181.DOI: 10.1038/s41467-021-27801-8.
|
| [23] |
刘欣健,崔正军,张树堂,等.曲安奈德联合5-氟尿嘧啶与单独曲安奈德治疗瘢痕疙瘩效果的荟萃分析[J].中华烧伤杂志,2020,36(12):1191-1198.DOI: 10.3760/cma.j.cn501120-20190930-00390.
|
| [24] |
LaRangerR,Karimpour-FardA,CostaC,et al.Analysis of keloid response to 5-fluorouracil treatment and long-term prevention of keloid recurrence[J].Plast Reconstr Surg,2019,143(2):490-494.DOI: 10.1097/PRS.0000000000005257.
|
| [25] |
中国整形美容协会瘢痕医学分会.瘢痕早期治疗全国专家共识(2020版)[J].中华烧伤杂志,2021,37(2):113-125.DOI: 10.3760/cma.j.cn501120-20200609-00300.
|
| [26] |
YuanB,UptonZ,LeavesleyD,et al.Vascular and collagen target: a rational approach to hypertrophic scar management[J].Adv Wound Care (New Rochelle),2023,12(1):38-55.DOI: 10.1089/wound.2020.1348.
|
| [27] |
OgawaR,AkitaS,AkaishiS,et al.Diagnosis and treatment of keloids and hypertrophic scars-Japan Scar Workshop consensus document 2018[J/OL].Burns Trauma,2019,7:39[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/31890718/.DOI: 10.1186/s41038-019-0175-y.
|
| [28] |
WenandeE,AndersonRR,HaedersdalM.Fundamentals of fractional laser-assisted drug delivery: an in-depth guide to experimental methodology and data interpretation[J].Adv Drug Deliv Rev,2020,153:169-184.DOI: 10.1016/j.addr.2019.10.003.
|
| [29] |
光电技术治疗皮肤创伤性瘢痕专家共识(2018版)编写组.光电技术治疗皮肤创伤性瘢痕专家共识(2018版)[J].中华烧伤杂志,2018,34(9):593-597.DOI: 10.3760/cma.j.issn.1009-2587.2018.09.007.
|
| [30] |
CavaliéM,SillardL,MontaudiéH,et al.Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases[J].Dermatol Ther,2015,28(2):74-78.DOI: 10.1111/dth.12187.
|
| [31] |
TawaranurakN,PliensiriP,TawaranurakK.Combination of fractional carbon dioxide laser and topical triamcinolone vs intralesional triamcinolone for keloid treatment: a randomised clinical trial[J].Int Wound J,2022,19(7):1729-1735.DOI: 10.1111/iwj.13775.
|
| [32] |
HuangH,WangW.Molecular mechanisms of glucocorticoid resistance[J].Eur J Clin Invest,2023,53(2):e13901.DOI: 10.1111/eci.13901.
|
| [33] |
QuaxRA,ManenschijnL,KoperJW,et al.Glucocorticoid sensitivity in health and disease[J].Nat Rev Endocrinol,2013,9(11):670-686.DOI: 10.1038/nrendo.2013.183.
|
| [34] |
LiJ,Hlavka-ZhangJ,ShrimpJH,et al.PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia[J].Cancer Discov,2022,12(1):186-203.DOI: 10.1158/2159-8290.CD-20-1771.
|
| [35] |
LiLB,LeungDY,MartinRJ,et al.Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma[J].Am J Respir Crit Care Med,2010,182(7):877-883.DOI: 10.1164/rccm.201001-0015OC.
|
| [36] |
XavierAM,AnunciatoAK,RosenstockTR,et al.Gene expression control by glucocorticoid receptors during innate immune responses[J].Front Endocrinol (Lausanne),2016,7:31.DOI: 10.3389/fendo.2016.00031.
|
| [37] |
SevillaLM,Jiménez-PanizoA,Alegre-MartíA,et al.Glucocorticoid resistance: interference between the glucocorticoid receptor and the MAPK signalling pathways[J].Int J Mol Sci,2021,22(18):10049.DOI: 10.3390/ijms221810049.
|
| [38] |
ZhuH,LiJ,LiY,et al.Glucocorticoid counteracts cellular mechanoresponses by LINC01569-dependent gluco-corticoid receptor-mediated mRNA decay[J].Sci Adv,2021,7(9):eabd9923.DOI: 10.1126/sciadv.abd9923.
|
| [1] | Mu Zelan, Teng Yongxiang, Zhang Jian, Bai Nan, Fu Yanjie. Research advances on the roles of metabolic remodeling and protein acylation modification in keloids[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(6): 589-593. doi: 10.3760/cma.j.cn501225-20231207-00229 |
| [2] | Liu Zhennan, Zhou Yuemin, Liu Ruoxuan, Li Yaling, Li Qing, Zhang Ting, Zhang Shuman. Clinical effects of pulsed dye laser dynamically combined with triamcinolone acetonide in the treatment of keloids[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(9): 822-829. doi: 10.3760/cma.j.cn501225-20220620-00249 |
| [3] | Zhang Mengyuan, Ding Gaofeng, He Qiong, Liu Jinling, Wang Tong, Zhang Baolin. Bibliometric and visual analysis of current status and trends of international research on keloids[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(3): 263-270. doi: 10.3760/cma.j.cn501120-20200226-00093 |
| [4] | Jia Chiyu, Chen Lingxi. Tumor characteristics of keloid[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(4): 301-305. doi: 10.3760/cma.j.cn501120-20200529-00289 |
| [5] | Liu Xinjian, Cui Zhengjun, Zhang Shutang, Su Weiguo, Meng Qingnan, Guo Pengfei, Wei Aizhou, Zhou Jian, Wang Changyin, Zou Shibo, Sun Jialin, Wang Xu. Meta-analysis of the effects of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating keloids[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(12): 1191-1198. doi: 10.3760/cma.j.cn501120-20190930-00390 |
| [6] | Guo Qige, Yao Min. Advances in the research of drug intralesional injection therapy in keloid[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(6): 415-418. doi: 10.3760/cma.j.issn.1009-2587.2018.06.024 |
| [7] | Fan Youfen, Cui Shengyong, Zhang Chun, Xu Xiaomin. Investigation of acquired drug-resistant genes and strains relationship in Pseudomonas aeruginosa isolated from burn patients[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(2): 83-87. doi: 10.3760/cma.j.issn.1009-2587.2018.02.005 |
| [8] | Liu Shan, Wang Chen, Fu Yuexian. Analysis of drug resistance of Acinetobacter baumannii in wound of children with traffic injury and its relationship with antibiotic use[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(7): 404-409. doi: 10.3760/cma.j.issn.1009-2587.2017.07.002 |
| [9] | Chen Junjie, Wu Xiaojing, Zhang Zhenyu, Chen Zhixing, Cen Ying. Study of the correlation between the expression of angiotensin Ⅱ and its receptors and collagen deposition in human keloid[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2016, 32(11): 653-657. doi: 10.3760/cma.j.issn.1009-2587.2016.11.004 |
| [11] | Song Mei, Liu Yi. Analysis on polymorphism at-509C/T site of TGF-β1 gene in patients with keloids[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2014, 30(6): 482-486. doi: 10.3760/cma.j.issn.1009-2587.2014.06.004 |
| [12] | XU Xiang, XU Jing-hong, WANG Hui-ming. Advances in the research of the effect of toll-like receptor in the formation of keloid[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2013, 29(4): 378-381. doi: 10.3760/cma.j.issn.1009-2587.2013.04.013 |
| [14] | WANG Da-li, ZHU Jing-jing, DENG Cheng-liang, WANG Bo, YU Li-mei. Identification of biological characteristics of human keloid-derived stem cells[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2011, 27(3): 210-214. doi: 10.3760/cma.j.issn.1009-2587.2011.03.016 |
| [15] | LIU Sijun, XIE You-fu, DAI Li-bing, DU Gao-wei. Expression of secretions of hypothalamus-pituitary-adrenal axis in human hypertrophic scar[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2011, 27(6): 432-435. doi: 10.3760/cma.j.issn.1009-2587.2011.06.007 |
| [16] | CHEN Zhong-yong, WANG Shi-liang, PENG Xi, WANG Feng-jun, ZHAO Yun, WANG Pei. Role of corticotropin releasing factor receptor 2 antisense oligodeoxynucleotide of hypothalamus in hypermetabolism in rats with severe burn[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2008, 24(6): 414-417. |
| [18] | HE Xiao-jie, HAN Chun-mao. Study on the expression of tenascin-C in keloid and hyperplastic scar[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2004, 20(2): 79-81. |
| [19] | LIU Wang, JIANG You-hui, LI You-liang, LIN Zi-hao, JIANG Hua, TAN Qian, ZHANG Jian-lin, WANG Zi-min. Experimental study on p53 gene mutation in keloid fibroblasts[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2004, 20(2): 85-87. |
Copyright © Chinese Journal of Burns京ICP备07035254号-14
E-mail：shaoshangzazhi@163.com
Supported by:
Beijing Renhe Information Technology Co. Ltd
Su YH,Xia WZ,Huang X,et al.Research advances in the treatment of keloid with glucocorticoids[J].Chin J Burns Wounds,2023,39(9):886-890.DOI: 10.3760/cma.j.cn501225-20230602-00198.
DownLoad: